{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T22:10:23Z","timestamp":1684879823713},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.042","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T17:03:11Z","timestamp":1233766991000},"page":"1700-1709","source":"Crossref","is-referenced-by-count":3,"title":["Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help"],"prefix":"10.1016","volume":"27","author":[{"given":"Shuchi","family":"Midha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2009.01.042_bib1","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6860","key":"10.1016\/j.vaccine.2009.01.042_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.vaccine.2009.01.042_bib3","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1073\/pnas.89.21.10277","article-title":"Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin","volume":"89","author":"Klimpel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"10.1016\/j.vaccine.2009.01.042_bib4","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.1016\/S0021-9258(17)32036-7","article-title":"Anthrax protective antigen forms oligomers during intoxication of mammalian cells","volume":"269","author":"Milne","year":"1994","journal-title":"J Biol Chem"},{"issue":"32","key":"10.1016\/j.vaccine.2009.01.042_bib5","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1021\/bi990792d","article-title":"Anthrax protective antigen: prepore-to-pore conversion","volume":"38","author":"Miller","year":"1999","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.042_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2672.1999.00889.x","article-title":"Mechanism of membrane translocation by anthrax toxin: insertion and pore formation by protective antigen","volume":"87","author":"Collier","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.042_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.200211018","article-title":"Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process","volume":"160","author":"Abrami","year":"2003","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.042_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20061891","article-title":"Manipulation of host signalling pathways by anthrax toxins","volume":"402","author":"Turk","year":"2007","journal-title":"Biochem J"},{"issue":"10","key":"10.1016\/j.vaccine.2009.01.042_bib9","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1073\/pnas.052160199","article-title":"The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen","volume":"99","author":"Mogridge","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2009.01.042_bib10","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.01.042_bib11","first-page":"189","article-title":"Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells","volume":"17","author":"Leppla","year":"1984","journal-title":"Adv Cyclic Nucleotide Protein Phosphorylation Res"},{"issue":"5364","key":"10.1016\/j.vaccine.2009.01.042_bib12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.042_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/0264-6021:3520739","article-title":"Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor","volume":"352","author":"Vitale","year":"2000","journal-title":"Biochem J"},{"issue":"5589","key":"10.1016\/j.vaccine.2009.01.042_bib14","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.1073163","article-title":"Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition","volume":"297","author":"Park","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.042_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.20041557","article-title":"Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling","volume":"201","author":"Paccani","year":"2005","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.042_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.jom.0000058345.05741.6b","article-title":"Analysis of adverse events after anthrax immunization in US Army medical personnel","volume":"45","author":"Wasserman","year":"2003","journal-title":"J Occup Environ Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.01.042_bib17","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/IAI.01722-07","article-title":"Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant","volume":"76","author":"Park","year":"2008","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.042_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2006.11.063","article-title":"PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice","volume":"331","author":"Ribeiro","year":"2007","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.042_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11095-005-9078-7","article-title":"Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.042_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-0556-3-3","article-title":"Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax","volume":"3","author":"Perkins","year":"2005","journal-title":"Genet Vaccines Ther"},{"issue":"37","key":"10.1016\/j.vaccine.2009.01.042_bib21","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.042_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijmm.2003.12.002","article-title":"Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination","volume":"294","author":"Hahn","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2009.01.042_bib23","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.01.042_bib24","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.01.042_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2009.01.042_bib26","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1093\/emboj\/cdf398","article-title":"Differential sorting and fate of endocytosed GPI-anchored proteins","volume":"21","author":"Fivaz","year":"2002","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.042_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.125.2.333","article-title":"Requirements for glycosylphosphatidylinositol attachment are similar but not identical in mammalian cells and parasitic protozoa","volume":"125","author":"Moran","year":"1994","journal-title":"J Cell Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.042_bib28","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1242\/jcs.108.6.2477","article-title":"Reassessment of the subcellular localization of p63","volume":"108","author":"Schweizer","year":"1995","journal-title":"J Cell Sci"},{"issue":"43","key":"10.1016\/j.vaccine.2009.01.042_bib29","doi-asserted-by":"crossref","first-page":"42679","DOI":"10.1074\/jbc.M305695200","article-title":"Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4)","volume":"278","author":"Razzaq","year":"2003","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2009.01.042_bib30","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.4049\/jimmunol.156.7.2369","article-title":"Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes","volume":"156","author":"Ciernik","year":"1996","journal-title":"J Immunol"},{"issue":"5399","key":"10.1016\/j.vaccine.2009.01.042_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1126\/science.283.5399.225","article-title":"CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells","volume":"283","author":"Schofield","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2009.01.042_bib32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20050953","article-title":"Differential antitumor immunity mediated by NKT cell subsets in vivo","volume":"202","author":"Crowe","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.01.042_bib33","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.042_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/prep.1999.1066","article-title":"Expression and purification of the recombinant protective antigen of Bacillus anthracis","volume":"16","author":"Gupta","year":"1999","journal-title":"Prot Exp Purif"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.042_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mimet.2006.05.016","article-title":"Breaking down the wall: fractionation of mycobacteria","volume":"68","author":"Rezwan","year":"2007","journal-title":"J Microbiol Methods"},{"issue":"11","key":"10.1016\/j.vaccine.2009.01.042_bib36","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/IAI.00529-07","article-title":"In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity","volume":"75","author":"Staats","year":"2007","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.042_bib37","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.175.6.3762","article-title":"The influence of CD1d in postselection NKT cell maturation and homeostasis","volume":"175","author":"McNab","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.042_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1074-7613(00)80268-X","article-title":"Identification of the earliest B lineage stage in mouse bone marrow","volume":"5","author":"Li","year":"1996","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.042_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1096-9071(199707)52:3<275::AID-JMV7>3.0.CO;2-#","article-title":"Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines","volume":"52","author":"de Souza","year":"1997","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.042_bib40","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"12","key":"10.1016\/j.vaccine.2009.01.042_bib41","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.01.042_bib42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J Med Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.01.042_bib43","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect Immun"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.01.042_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.micpath.2005.02.001","article-title":"The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions","volume":"38","author":"Cote","year":"2005","journal-title":"Microb Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2009.01.042_bib45","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.042_bib46","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/IAI.72.6.3471-3477.2004","article-title":"Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine","volume":"72","author":"Marcus","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.042_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/IAI.74.1.394-398.2006","article-title":"Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits","volume":"74","author":"Weiss","year":"2006","journal-title":"Infect Immun"},{"issue":"5356","key":"10.1016\/j.vaccine.2009.01.042_bib48","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.279.5356.1541","article-title":"Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol","volume":"279","author":"Joyce","year":"1998","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2009.01.042_bib49","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.4049\/jimmunol.145.10.3209","article-title":"Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+CD4-CD8- and alpha beta TCR+NK1. 1+ cells","volume":"145","author":"Sykes","year":"1990","journal-title":"J Immunol"},{"issue":"6011","key":"10.1016\/j.vaccine.2009.01.042_bib50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2009.01.042_bib51","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.20021616","article-title":"CD1d-restricted help to B cells by human invariant natural killer T lymphocytes","volume":"197","author":"Galli","year":"2003","journal-title":"J Exp Med"},{"issue":"6695","key":"10.1016\/j.vaccine.2009.01.042_bib52","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/29570","article-title":"Microdomains of GPI-anchored proteins in living cells revealed by crosslinking","volume":"394","author":"Friedrichson","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.042_bib53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.20050773","article-title":"Human CD1-restricted T cell recognition of lipids from pollens","volume":"202","author":"Agea","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.042_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.70.1.292-302.2002","article-title":"DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in mouse model of pulmonary tuberculosis","volume":"70","author":"Delogu","year":"2002","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.01.042_bib55","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/IAI.67.9.4780-4786.1999","article-title":"Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences","volume":"67","author":"Li","year":"1999","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T21:36:37Z","timestamp":1684877797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001327"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}